Clinical Trial Update: Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating lapatinib or trastuzumab before surgery with chemotherapy in patients with early breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 2 | Status: WITHDRAWN